🇺🇸 FDA
Patent

US 11981736

Antibodies specific to glycosylated PD-1 and methods of use thereof

granted A61KA61K39/395A61K47/6849

Quick answer

US patent 11981736 (Antibodies specific to glycosylated PD-1 and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K39/395, A61K47/6849, A61K9/0019, A61P